Research Output per year
The Cell Therapies Platform provides a flexible, cost-effective alternative to traditional cell therapy manufacturing and regenerative medicine facilities. Available to researchers and commercial entities from within and out with the MHTP seeking to progress cell and tissue based therapies to the clinic. The platform houses the BioSpherix Xvivo GMP Isolator, an enclosed, integrated and fully controlled environment for cell and tissue processing. The Miltenyi MACSQuant Tyto clinical cell sorter and the GeSim BioScaffolder with 3D biological printing and melt electrospinning capabilities.
3D bioprinted endometrial stem cells on melt electrospun poly ε-caprolactone mesh for pelvic floor application promote anti-inflammatory responses in micePaul, K., Darzi, S., McPhee, G., Del Borgo, M. P., Werkmeister, J. A., Gargett, C. E. & Mukherjee, S., 1 Oct 2019, In : Acta Biomaterialia. 97, p. 162-176 15 p.
Research output: Contribution to journal › Article › Research › peer-review